Yıl: 2019 Cilt: 16 Sayı: 1 Sayfa Aralığı: 23 - 29 Metin Dili: İngilizce İndeks Tarihi: 23-07-2019

The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen

Öz:
Aerobic, non-fermentative and Gram-negative Stenotrophomonas maltophilia is a multidrug-resistant bacilli that is known to be pathogen for human and animals. S. maltophilia has been isolated from different animal species and also found in a variety of environments including soil, water, and plants. S. maltophilia, which has the ability to form biofilms on surfaces that cause environmental problems, is resistant to many antibiotic classes such as cephalosporins, carbapenems, and aminoglycosides. Here in this study, its aimed to determine the inhibition activities of natural phenolic compounds eugenol and pulegone against S. maltophilia MU69. Antibacterial activities of eugenol and pulegone were initially determined by disc diffusion method. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) were also determined by tube dilution assay. Antibiofilm activities of the compounds were investigated by crystal violet staining and also monitorized using Scanning Electron Microscopy (SEM). Zone of inhibition measurements were found to be 39 mm and 28 mm for eugenol and pulegone, respectively. MIC and MBC values were found to be 3.12 mg/mL for eugenol while these were 2.5 mg/mL and 5 mg/mL for pulegone, respectively. The highest antibiofilm activity was found to be 56.30±0.45% for MIC of eugenol. To our knowledge, this is the first report of the antibacterial and antibiofilm activity of eugenol and pulegone against S. maltophilia. According to the biological activity results, it can be concluded that these natural agents may be potentially used for veterinary sciences, food industry or pharmaceutical applications that aim to manage S. maltophilia biofilm.
Anahtar Kelime:

Konular: Veterinerlik

Eugenol ve Pulegonun Fırsatçı Patojen Bir Bakteri Olan Stenotrophomonas maltophilia’ya Karşı İnhibisyon Etkinliğinin Belirlenmesi

Öz:
Aerobik, non-fermentatif ve gram-negatif Stenotrophomonas maltophilia, insan ve hayvanlar için patojen olarak bilinen çoklu ilaç direncine sahip bir basildir. Farklı hayvan türlerinden izole edilmiş S. maltophilia suşu toprak, su ve bitkiler gibi çeşitli çevresel etmenlerden de izole edilebilmektedir. Katı yüzeyler üzerinde biyofilm oluşturabilme yeteneği sayesinde S. maltophilia suşu çevre sorunlarına yol açmakla birlikte aminoglikozitler, karbapenemler ve sefalosporinler gibi çeşitli antibiyotik sınıflarına karşı direnç göstermektedir. Bu çalışmada doğal fenolik bileşikler olan eugenol ve pulegonun S. maltophila MU69 suşu üzerindeki inhibisyon aktivitelerinin belirlenmesi amaçlanmıştır. Eugenol ve pulegonun antibakteriyel aktivitesi disk difüzyon yöntemi ile araştırılmıştır. Minimum İnhibisyon Konsatrasyonu (MİK) ve Minimum Bakterisidal Konsantrasyon (MBK) ise tüp dilüsyon yöntemi ile belirlenmiştir. Antibiyofilm aktivitenin belirlenmesinde kristal viyole boyama yöntemi uygulanmış ve ayrıca Taramalı Elektron Mikroskobi (SEM) ile görüntülenmiştir. Eugenol ve pulegon için inhibisyon zonu sırasıyla 39 mm ve 28 mm olarak ölçülmüştür. MİK ve MBK değerleri eugenol için 3.12 mg/mL olarak belirlenirken, pulegon için sırasıyla 2.5 mg/mL ve 5 mg/mL olarak tespit edilmiştir. En yüksek antibiyofilm aktivite oranı % 56.30±0.45 ile eugenole ait MİK değeri için gözlenmiştir. Bu çalışma eugenol ve pulegon bileşiklerinin S. maltophilia suşuna karşı antibakteriyel ve antibiyofilm aktivitelerinin belirlendiği ilk çalışma olarak sunulmaktadır. Biyolojik aktivite çalışmalarının sonuçlarına göre bu iki doğal bileşik veteriner bilimleri, gıda endüstrisi ve farmasötik uygulamalarda S. maltophilia’ya karşı geliştirilen sistemlerde potansiyel kullanım kapasitesine sahiptir.
Anahtar Kelime:

Konular: Veterinerlik
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Albini S, Abril C, Franchini M, Hüssy D, Filioussis G. Stenotrophomonas maltophilia isolated from the airways of animals with chronic respiratory disease. Schweiz Arch Tierheilkd 2009; 151(7): 323-8.
  • Ali SM, Khan AA, Ahmed I, Musaddiq M, Ahmed KS, Polasa H, Ahmed N. Antimicrobial activities of Eugenol and Cinnamaldehyde against the human gastric pathogen Helicobacter pylori. Ann Clin Microbiol Antimicrob 2005; 4(20): 1-7.
  • Alonso A, Martinez JL. Multiple antibiotic resistan-ce in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 1997; 41:1140-2.
  • Al-Shabib NA, Husain FM, Ahmad I, Baig MH. Eugenol inhibits quorum sensing and biofilm of toxigenic MRSA strains isolated from food hand-lers employed in Saudi Arabia. Biotechnol Bio-technol Equip 2017; 31(2): 387-96.
  • Avison MB, Higgins CS, von Heldreich CJ, Ben-nett PM, Walsh TR. Plasmid location and molecu-lar heterogeneity of the L1 and L2-lactamase ge-nes of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2001; 45(2):413-9.
  • Avison MB, von Heldreich CJ, Higgins CS, Ben-nett PM, Walsh TR. ATEM-2_-lactamase encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia. J Antimicrob Chemother 2000; 46(6): 879-84.
  • Bassolé IHN, Juliani HR. Essential oils in combi- nation and their antimicrobial proper-ties. Molecules 2012; 17(4): 3989-4006.
  • Baygar T, Ugur A. In vitro evaluation of antimicro-bial and antibiofilm potentials of silver nanopartic-les biosynthesized by Streptomyces griseo-rubens. IET Nanobiotechnol 2017; 11(6): 667-81.
  • Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Mic-robiol Rev 2012; 25(1): 2-41.
  • Chung HS, Hong SG, Kim YR, Shin KS, Whang DH, Ahn JY, Lee HS. Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinati-ons against the isolates. J Korean Med Sci 2013;28 (1): 62-6.
  • CLSI-Clinical and Laboratory Standards Institute. Performance standards for antimicrobial suscepti-bility testing. Sixteenth Informational Supplement. Document M100-S16, Wayne, PA: Clinical and Laboratory Standards Institute, 2011.
  • Collins CH, Lyne PM, Grange JM, eds, Microbio-logical Methods, 7th ed, Butterworths, London, 1995; p.493.
  • Crossman LC, Gould VC, Dow JM, Vernikos GS, Okazaki A, Sebaihia M, Adlem E. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an orga-nism heavily shielded by drug resistance determi-nants. Genome Biol 2008; 9(4): 1-13.
  • Çıkman A, Parlak M, Bayram Y, Güdücüoğlu A, Berktaş M. Antibiotics resistance of Stenotropho-monas maltophilia strains isolated from various clinical specimens. Afr Health Sci 2016; 16 (1): 149-52.
  • de Oliveira-Garcia D, Dall'Agnol M, Rosales M, Azzuz A, Alcántara N, Martinez M, Girón J. Fimb-riae and adherence of Stenotrophomonas maltop-hilia to epithelial cells and to abiotic surfaces. Cell Microbiol 2003; 5: 625-36.
  • Devi KP, Nisha SA, Sakthivel R, Pandian SK. Eugenol (an essential oil of clove) acts as an anti-bacterial agent against Salmonella typhi by dis-rupting the cellular membrane. J Ethnopharmacol 2010; 130(1): 107-15.
  • Draper CS, Walker RD, Lawler HE. Patterns of oral bacterial infection in captive snakes. J Am Vet Med Assoc 1981; 179(11): 1223-6.
  • Duru ME, Öztürk M, Uğur A, Ceylan Ö. The cons-tituents of essential oil and in vitro antimicrobial activity of Micromeria cilicica from Turkey. J Eth nopharmacol 2004; 94(1): 43-8.
  • El Abed N, Kaabi B, Smaali MI, Chabbouh M, Habibi K, Mejri M, Ben Hadj Ahmed S. Chemical composition, antioxidant and antimicrobial activi-ties of Thymus capitata essential oil with its pre-servative effect against Listeria monocytogenes inoculated in minced beef meat. Evid Based Complement Alternat Med 2014; 2014:1-12.
  • Filgueiras CT, Vanetti MCD. Effect of eugenol on growth and listeriolysin o production by Listeria monocytogenes. Braz Arch Biol Technol 2006; 49 (3): 405-9.
  • Geng Y, Wang K, Chen D, Huang X, He M, Yin Z. Stenotrophomonas maltophilia, an emerging op-portunist pathogen for cultured channel catfish, Ictalurus punctatus, in China. Aquaculture 2010; 308(3): 132-5.
  • Harborne JB, Baxter H, Moss GP. Dictionary of Plant Toxins. Chichester. John Wiley and Sons, 1996; p. 310-1.
  • Harris NB, Rogers DG. Septicemia associated with Stenotrophomonas maltophilia in a West African dwarf crocodile (Osteolaemus tetraspis subsp. tetraspis). J Vet Diagn Investig 2001; 13(3): 255-8.
  • Hu LF, Chang X, Ye Y, Wang ZX, Shao YB, Shi W, Li JB. Stenotrophomonas maltophilia resistan-ce to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron. Int J Antimicrob Agents 2011; 37(3): 230-4.
  • Ito M, Murakami K, Yoshino M. Antioxidant action of eugenol compounds: role of metal ion in the inhibition of lipid peroxidation. Food Chem Toxicol 2005; 43(3): 461-6.
  • Johnson EH, Busaidy R, Hameed MS. An outb-reak of lymphadenitis associated with Stenotrop-homonas (Xanthomonas) maltophilia in Omani goats. J Vet Med B 2003; 50(2): 102-4.
  • Kapetanovic D, Kurtovic B, Vardic I, Teskeredtzic E, Teskeredzic Z. Gill disease in a gilthead sea bream (Sparus aurata L.). Medycyna Wet 2006; 62(11): 1239-41.
  • Khalil AA, ur Rahman U, Khan MR, Sahar A, Mehmood T, Khan M. Essential oil eugenol: sour-ces, extraction techniques and nutraceutical pers-pectives. RSC Advances 2017; 7(52): 32669-81.
  • Kim SS, Oh OJ, Min HY, Park EJ, Kim Y, Park HJ, Lee SK (2003). Eugenol suppresses cycloo-xygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264. 7 cells. Life sciences 2003; 73(3): 337-48.
  • Liaw SJ, Lee YL, Hsueh PR. Multidrug resistance in clinical isolates of Stenotrophomonas maltophi-lia: roles of integrons, efflux pumps, phosphoglu-comutase (SpgM), and melanin and biofilm forma-tion. Int J Antimicrob Agents 2010; 35(2): 126-30.
  • MacDiarmid JA, Burrell DH. Characterization of Pseudomonas maltophilia isolates from fleece rot. Appl Environ Microbiol 1986; 51(2): 346-8.
  • Mah TFC, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Micro- biol 2001; 9(1): 34-9.
  • Merritt JH, Kadouri DE, O'Toole GA. Growing and analyzing static biofilms. Curr Protoc Microbiol 2005; 22(1): 1-18.
  • Mkaddem M, Bouajila J, Ennajar M, Lebrihi A, Mathieu F, Romdhane M. Chemical composition and antimicrobial and antioxidant activities of Mentha (longifolia L. and viridis) essential oils. J Food Sci 2009; 74(7): 358-63.
  • Prasad SN. Neuroprotective efficacy of eugenol and isoeugenol in acrylamide-induced neuropathy in rats: behavioral and biochemical eviden-ce. Neurochem Res 2013; 38(2): 330-45.
  • Rauscher FM, Sanders RA, Watkins JB. Effects of isoeugenol on oxidative stress pathways in nor-mal and streptozotocin‐induced diabetic rats. J Biochem Mol Toxicol 2001; 15(3): 159-164.
  • Soković M, Glamočlija J, Marin PD, Brkić D, van Griensven LJ. Antibacterial effects of the essential oils of commonly consumed medicinal herbs using an in vitro model. Molecules 2010; 15(11): 7532-46.
  • Sousa DPD, Nóbrega FF, de Lima MR, Almeida RND. Pharmacological activity of (R)-(+)-pulegone, a chemical constituent of essential oils. Z Naturforsch C 2011; 66(7-8): 353-9.
  • Srinivasan S, Sathish G, Jayanthi M, Muthukuma-ran J, Muruganathan U, Ramachandran V. Ameli-orating effect of eugenol on hyperglycemia by attenuating the key enzymes of glucose metabo-lism in streptozotocin-induced diabetic rats. Mol Cell Biochem 2014; 385(1-2): 159-68.
  • Upadhyay A, Upadhyaya I, Kollanoor-Johny A, Venkitanarayanan K. Antibiofilm effect of plant derived antimicrobials on Listeria monocytoge-nes. Food microbiology 2013; 36(1): 79-89.
  • Vartivarian S, Anaissie E, Bodey G, Sprigg H, Rolston KA changing pattern of susceptibility of Xanthamonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Che-mother 1994; 38: 624-7.
  • Venkadeswaran K, Muralidharan AR, Annadurai T, Ruban VV, Sundararajan M, Anandhi R, Geral-dine P. Antihypercholesterolemic and antioxidati-ve potential of an extract of the plant, Piper betle, and its active constituent, eugenol, in triton WR-1339-Induced hypercholesterolemia in experimen-tal rats. Evid Based Complementary Altern Med 2014: 1-11.
  • Vidhy N, Devaraj SN. Induction of apoptosis by eugenol in human breast cancer cells. Indian J Exp Biol 2011; 49(11): 871-78.
  • Walsh SE, Maillard JY, Russell AD, Catrenich CE, Charbonneau DL, Bartolo RG. Activity and mec-hanisms of action of selected biocidal agents on Gram‐positive and‐negative bacteria. J Appl Mic-robiol 2003; 94(2): 240-7.
  • Yogalakshmi B, Viswanathan P, Anuradha CV. Investigation of antioxidant, anti-inflammatory and DNA-protective properties of eugenol in thioaceta-mide-induced liver injury in rats. Toxicology 2010; 268(3): 204-12.
  • Zhang L, Xian-Zhi L, Poole K. Multiple Antibiotic Resistance in Stenotrophomonas maltophilia: Involvement of a Multidrug Efflux System. Anti-microb Agents Chemother 2000; 44(2): 287-93.
  • Zhou YC, Zhu, CH, Zhang B. Isolation and pre-vention of the pathogen causing large scale death on Trachinotus ovatus. Mar Sci 2001; 25(4): 40-4.
APA BAYGAR T, Sarac N, Ugur A, BAYGAR T, Balcı U (2019). The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen. , 23 - 29.
Chicago BAYGAR Tuba,Sarac Nurdan,Ugur Aysel,BAYGAR TAÇNUR,Balcı Uydu The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen. (2019): 23 - 29.
MLA BAYGAR Tuba,Sarac Nurdan,Ugur Aysel,BAYGAR TAÇNUR,Balcı Uydu The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen. , 2019, ss.23 - 29.
AMA BAYGAR T,Sarac N,Ugur A,BAYGAR T,Balcı U The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen. . 2019; 23 - 29.
Vancouver BAYGAR T,Sarac N,Ugur A,BAYGAR T,Balcı U The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen. . 2019; 23 - 29.
IEEE BAYGAR T,Sarac N,Ugur A,BAYGAR T,Balcı U "The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen." , ss.23 - 29, 2019.
ISNAD BAYGAR, Tuba vd. "The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen". (2019), 23-29.
APA BAYGAR T, Sarac N, Ugur A, BAYGAR T, Balcı U (2019). The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen. Erciyes Üniversitesi Veteriner Fakültesi Dergisi, 16(1), 23 - 29.
Chicago BAYGAR Tuba,Sarac Nurdan,Ugur Aysel,BAYGAR TAÇNUR,Balcı Uydu The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen. Erciyes Üniversitesi Veteriner Fakültesi Dergisi 16, no.1 (2019): 23 - 29.
MLA BAYGAR Tuba,Sarac Nurdan,Ugur Aysel,BAYGAR TAÇNUR,Balcı Uydu The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen. Erciyes Üniversitesi Veteriner Fakültesi Dergisi, vol.16, no.1, 2019, ss.23 - 29.
AMA BAYGAR T,Sarac N,Ugur A,BAYGAR T,Balcı U The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen. Erciyes Üniversitesi Veteriner Fakültesi Dergisi. 2019; 16(1): 23 - 29.
Vancouver BAYGAR T,Sarac N,Ugur A,BAYGAR T,Balcı U The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen. Erciyes Üniversitesi Veteriner Fakültesi Dergisi. 2019; 16(1): 23 - 29.
IEEE BAYGAR T,Sarac N,Ugur A,BAYGAR T,Balcı U "The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen." Erciyes Üniversitesi Veteriner Fakültesi Dergisi, 16, ss.23 - 29, 2019.
ISNAD BAYGAR, Tuba vd. "The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen". Erciyes Üniversitesi Veteriner Fakültesi Dergisi 16/1 (2019), 23-29.